Open access

COVID-19 vaccines in the WHO's Emergency Use Listing (EUL) Report (10) - 15.12.2021

MandatorSwiss Federal Office of Public Health (FOPH)
Number of pages118
PublisherBern : Swiss School of Public Health plus (SSPH+)
  • COVID-19 vaccines in the WHO's Emergency Use Listing (EUL) Report; 10
Publication date2021-12-15
First online date2021-12-15

This report provides an in-depth review of the seven1 World Health Organization's (WHO) Emergency Use Listing (EUL) authorized vaccines: BNT162b2/ COMIRNATY (Pfizer-BioNTech, USA), Spikevax/ Moderna COVID-19 Vaccine/ mRNA-1273 (Moderna, USA), Vaxzevria/ ChAdOx1 nCoV-19/ AZD1222/ Covishield (AstraZeneca/Oxford, UK, India), Janssen Covid-19 vaccine/ Ad26CoV2.S/ Johnson & Johnson (Janssen, USA), Sinopharm/ BBIBP-CorV (China), Sinovac/ CoronaVac (China), and COVAXIN/ BBV152 (Bharat Biotech, India)]. The current report summarises the latest data on COVID-19 vaccine-related literature as of 13 December 2021, and presents the information in the form of a synoptic table. This report covers vaccine effectiveness, protection against variants, transmissibility, breakthrough infections, booster doses, COVID-19 vaccines for children, and further important information for each vaccine. The latest changes and additions to the synoptic table are highlighted in yellow.

Citation (ISO format)
RODRIGUEZ VELÁSQUEZ, Sabina et al. COVID-19 vaccines in the WHO’s Emergency Use Listing (EUL) Report (10) - 15.12.2021. 2021
Main files (1)
  • PID : unige:157782

Technical informations

Creation01/07/2022 3:38:00 PM
First validation01/07/2022 3:38:00 PM
Update time03/16/2023 2:18:52 AM
Status update03/16/2023 2:18:52 AM
Last indexation01/29/2024 11:15:08 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack